tiprankstipranks
Trending News
More News >
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market

Shield Therapeutics (STX) Technical Analysis

Compare
39 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is 0.92, suggesting Shield Therapeutics PLC is a Sell.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 9.99, while Shield Therapeutics PLC’s (STX) share price is 11.75p, making it a Buy.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 8.73, while Shield Therapeutics PLC’s (STX) share price is 11.75p, making it a Buy.

Shield Therapeutics (STX) Pivot Points

Dec 19, 2025, 10:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.63
10.07
10.63
11.07
11.63
12.07
12.63
Fibonacci
10.07
10.45
10.68
11.07
11.45
11.68
12.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Dec 19, 2025, 10:14 AM
Period
Simple
Exponential
MA5
10.83Buy
11.06Buy
MA10
10.79Buy
10.70Buy
MA20
9.93Buy
9.99Buy
MA50
8.27Buy
8.73Buy
MA100
7.58Buy
7.54Buy
MA200
5.21Buy
5.71Buy
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 10.70, while Shield Therapeutics PLC’s (STX) share price is 11.75p, making it a Buy.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 7.54, while Shield Therapeutics PLC’s (STX) share price is 11.75p, making it a Buy.
Shield Therapeutics PLC’s (STX) stock price is 11.75p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 8.27, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 11.75p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 7.58, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 11.75p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 5.21, creating a Buy signal.

Shield Therapeutics (STX) Technical Indicators

Dec 19, 2025, 10:14 AM
Name
Value
Implied Action
RSI (14)
72.43
Sell
STOCH (9,6)
58.64
Neutral
STOCHRSI (14)
66.27
Neutral
MACD (12,26)
0.92
Sell
ADX (14)
39.88
Neutral
Williams %R
-24.19
Buy
CCI (14)
109.97
Sell
ATR (14)
0.93
-
Ultimate Oscillator
59.59
Neutral
ROC
26.34
Buy
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 72.43, creating a Sell signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 39.88, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is 109.97, creating a Sell signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is 26.34, creating a Buy signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Strong Buy.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 72.43, which suggests STX is a Sell.
      What is STX’s MACD?
      STX’s MACD is 0.92, which suggests STX is a Sell.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 10.83, which suggests STX is a Buy.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 9.93, which suggests STX is a Buy.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 8.27, which suggests STX is a Buy.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 5.21, which suggests STX is a Buy.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -24.19, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is 109.97, which suggests STX is a Sell.
                    What is the share price of Shield Therapeutics PLC?